NASCOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Can B Corp
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.01−0.00 (-1.32%)
Close on Oct 19, 2026
- Market cap
- $981.54K
- P/E (TTM)
- –
- Dividend yield
- –
Can B Corp revenue by segment
By business segment
By product or service
| Revenue | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | Q2 23 | Q1 23 | Q4 22 | Q3 22 | Q2 22 | Q1 22 | Q4 21 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service [Member] | $15.27K | $272.29K | $369.10K | $300.74K | $222.88K | $165.45K | $130.56K | – | $258.49K | $355.74K | – | – | 100.0% | -93.1% |
| Product Sales [Member] | – | – | – | – | – | – | $808.75K | $668.74K | $2.63M | $915.26K | $1.31M | $1.80M | – | – |
| Service Revenue [Member] | – | – | – | – | – | – | $130.56K | – | $258.49K | $355.74K | $549.92K | $183.70K | – | – |
| Product [Member] | – | – | – | $76.15K | $196.08K | $255.14K | $808.75K | $668.74K | $2.63M | $915.26K | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of Can B's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.